OWKIN Integrates 10x Genomics Spatial Omics and Single-Cell Technologies to the MOSAIC Study
November 6, 2023
PLEASANTON, Calif. and PARIS -- OWKIN and 10x Genomics, Inc. (Nasdaq: TXG), announce they have entered into an agreement to add 10x Genomics spatial omics and single-cell technologies to the ambitious MOSAIC project, which has already garnered attention for its pioneering work in tumor analysis for therapeutic discovery. Unveiled in June 2023, MOSAIC is a landmark $50 [...]
November 6, 2023
Automation combined with on-line monitoring during the cell expansion step can bring cell therapy manufacturing efficiencies and enable increased patient accessibility and safety BOSTON & LAKEWOOD, Colo.-- 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, and medical technology company Terumo Blood and Cell Technologies (Terumo BCT) announce a [...]
QIAGEN launches complete Sample to Insight workflow for microbiome research
November 6, 2023
Simplified and accelerated research workflow including high-quality DNA extraction kits, library preparation for whole genome metagenomics, and user-friendly bioinformatics analysis // Workflow enables diverse microbiome research applications, including gut health, soil microbiology, and antibiotic resistance, maximizing DNA diversity and minimizing bias // Expanding growing portfolio of QIAGEN microbiome solutions, covering every aspect of the scientific [...]
Joe Stringer appointed Executive Chairman and Director of Corporate Development (EMEA)
November 6, 2023
Former lead investor joins business full-time bringing long track record in healthcare technology London, UK — Automata Technologies (‘Automata’ or the ‘Company’), a leading automation company powering life sciences labs, has appointed Joe Stringer Executive Chairman and Director of Corporate Development (EMEA) for the UK and EMEA. Following Automata’s recent $40m fundraise, the appointment comes as it accelerates its [...]
November 6, 2023
A joint proposal for research and development on the social implementation of cultivated wagyu beef, submitted by Fujimori Kogyo Co., Ltd. (ZACROS), TOPPAN Holdings Inc. (TOPPAN Holdings), and Shimadzu Corporation (Shimadzu), has been accepted by Japan’s New Energy and Industrial Technology Development Organization (NEDO) and earmarked for implementation by the three companies under NEDO’s program [...]
Proteintech Genomics launches new MultiPro Immune Profiling Cocktail
November 6, 2023
The first commercially available solution for the detection of intracellular proteins for single-cell RNAseq experiments SAN DIEGO, CA – Proteintech Genomics, a subsidiary of Proteintech Group, Inc., and a provider of multiomic solutions for single-cell and spatial analysis, announced the launch of the MultiProTM Human Fixed Cell Immune Profiling Antibody Cocktail. This cocktail contains 53 antibodies against intracellular and [...]
SepSolve Analytical launches new INSIGHT-Thermal modulator for GC×GC
November 6, 2023
SepSolve Analytical has expanded its GC×GC product offering through the addition of a new modulator. The new INSIGHT-Thermal sits alongside SepSolve’s existing INSIGHT-Flow modulator, enabling the company to now provide GC×GC analysts with outstanding performance whatever their application needs, from research through to routine analyses. Both INSIGHT-Flow and INSIGHT-Thermal are fully compatible with GCs from [...]
November 3, 2023
New Kit offers BioXp automation workflow from candidate sequence to amplified DNA in days SAN DIEGO -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp® De novo Cloning and Amplification kit on the BioXp 3250 and BioXp 9600 systems. This cell-free [...]
Evident Aligns Business Unit Structure to Best Meet Customer Needs
November 3, 2023
Evident was established as a standalone company in April 2023, comprising the former Scientific Solutions business of Olympus, marking a significant milestone in the development of our new company. Building on our proven track record of innovation in imaging, instrumentation, and measurement solutions, we are excited to announce we have reorganized our internal structure into [...]
November 3, 2023
Former Quantapore founder and CEO brings 20 years of proteomics and genomics industry experience to company developing a platform for comprehensively quantifying the proteome SEATTLE -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the expansion of its research and development senior [...]

